Details of the Drug

General Information of Drug (ID: DMPFJOP)

Drug Name

US-APR2020

Indication

Disease Entry	ICD 11	Status	REF
Chronic kidney disease	GB61	Phase 2/3	[1]
------------------------------------------------------------------------------------

Drug Type

Live biotherapeutic

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05407389) An Open-Label Rollover Extension Phase 2 Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study. U.S.National Institutes of Health.